Next Generation PrEP (R01)

The summary for the Next Generation PrEP (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Next Generation PrEP (R01): Purpose. The National Institute of Allergy and Infectious Diseases (NIAID) encourages applications from institutions/organizations to participate in this Funding Opportunity Announcement (FOA), Next Generation PrEP. The purpose of this FOA is to: Develop the basic and preclinical framework needed for development of second and subsequent generations of PrEP agents; Create a rational pipeline for the discovery of New Molecular Entities (NMEs) and the identification of existing antiretrovirals (approved for HIV treatment, and those that are not approved but may have extensive clinical data) that can be used for the next generation of PrEP agents; Develop preclinical algorithms with clear go/no go criteria for identifying and prioritizing PrEP candidates for advancement to clinical evaluation; Generate PK/PD models to assess protective effects at mucosal sites of HIV transmission; and Conduct proof-of-concept safety and efficacy studies in animal models. Mechanism of Support. This FOA will utilize the NIH Research project (R01) grant mechanism. Funds Available and Anticipated Number of Awards. NIAID intends to commit approximately $1.8M in FY 2011 to fund 3-5 applications submitted in response to this FOA. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications
Federal Grant Title: Next Generation PrEP (R01)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-AI-10-012
Type of Funding: Grant
CFDA Numbers: 93.855
CFDA Descriptions: Allergy, Immunology and Transplantation Research
Current Application Deadline: Nov 02, 2010
Original Application Deadline: Nov 02, 2010
Posted Date: May 27, 2010
Creation Date: May 27, 2010
Archive Date: Dec 03, 2010
Total Program Funding: $1,800,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed)
Center of Excellence for Systems Modeling of Infection and Immunity across Biological Scal...
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Tria...
Novel Approaches for Radiation Biodosimetry Assays and Devices Development (U01 Clinical T...
Center for HIV/AIDS Vaccine Immunology (CHAVI)
Genomics of Transplantation Cooperative Research Program
Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com